Corrigendum to "Quercitrin loaded cyclodextrin based nanosponge as a promising approach for management of lung cancer and COVID-19" [J. Drug Deliv. Sci. Technol. 77 (2022) 103921].
Autor: | Taleb SA; Pharmaceutical Technology Department, National Research Centre, El-Buhouth Street, Dokki, Cairo, 12622, Egypt., Moatasim Y; Center of Scientific Excellence for Influenza Viruses, National Research Centre, El-Buhouth Street, Dokki, Cairo, 12622, Egypt., GabAllah M; Center of Scientific Excellence for Influenza Viruses, National Research Centre, El-Buhouth Street, Dokki, Cairo, 12622, Egypt., Asfour MH; Pharmaceutical Technology Department, National Research Centre, El-Buhouth Street, Dokki, Cairo, 12622, Egypt. |
---|---|
Jazyk: | angličtina |
Zdroj: | Journal of drug delivery science and technology [J Drug Deliv Sci Technol] 2023 Aug; Vol. 85, pp. 104576. Date of Electronic Publication: 2023 May 22. |
DOI: | 10.1016/j.jddst.2023.104576 |
Abstrakt: | [This corrects the article DOI: 10.1016/j.jddst.2022.103921.]. (© 2023 Elsevier B.V. All rights reserved.) |
Databáze: | MEDLINE |
Externí odkaz: |